12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Eli Lilly preclinical data

In a mouse model of medulloblastoma, oral LY2940680 significantly improved survival vs. controls. The small molecule...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >